Q1 EPS Estimate for ARS Pharmaceuticals Lowered by Analyst
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of ARS Pharmaceuticals in a research report issued to clients and investors on Thursday, March 20th. William Blair analyst L. Hanbury-Brown now forecasts that the company will post earnings of ($0.35) per share for the […]
ARS Pharmaceuticals, Inc. (NASDAQ:SPRY – Free Report) – Analysts at William Blair reduced their Q1 2025 earnings estimates for shares of ARS Pharmaceuticals in a research report issued to clients and investors on Thursday, March 20th. William Blair analyst L. Hanbury-Brown now forecasts that the company will post earnings of ($0.35) per share for the […]
